The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The oncolytic virus therapy market is anticipated to expand from $0.12 billion in 2022 to $0.15 billion in 2023, marking a 26.7% CAGR. By 2027, it is projected to reach $0.36 billion, with a CAGR of 24.6%.

Oncolytic virus therapy, or virotherapy, employs viruses to specifically infect and replicate within cancer cells, sparing healthy cells in the body. It’s a cancer treatment approach with genetically modified or naturally occurring viruses.

Read More On The Oncolytic Virus Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report

Oncolytic Virus Therapy Market Driver
The rising cancer incidence will likely drive the oncolytic virus therapy market. Cancer encompasses various diseases involving uncontrolled cell growth. Oncolytic virus therapy has the potential to target and eliminate cancer cells while activating an immune response, presenting a dual-action approach to effective cancer treatment. In 2020, based on data from Globocan, an organization tracking global cancer statistics, approximately 19.29 million new cancer cases were reported, with a projected 50.55 million cases over five years. Consequently, increasing cancer prevalence is set to boost the oncolytic virus therapy market.

Oncolytic Virus Therapy Market Trends
Innovation in products is a prominent trend in the oncolytic virus therapy market. Leading companies in this sector are dedicated to introducing inventive products to maintain their market standing. An example of this is seen in Daiichi Sankyo Company Limited, a Japanese pharmaceutical firm, which launched DELYTACT in Japan during November 2021. DELYTACT stands out as the first oncolytic virus approved for primary brain cancer across all regions. It features a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1) designed to selectively replicate and eliminate tumor cells while leaving normal tissues unharmed.

Request for A Sample Of The Global Oncolytic Virus Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=12391&type=smp

Major Players And Regions Of The Oncolytic Virus Therapy Market
Major players in the oncolytic virus therapy market are Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Eurofins Scientific SE, Recipharm AB, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics, and SillaJen Inc.

North America was the largest region in the oncolytic virus therapy market in 2022.

Oncolytic Virus Therapy Market Segmentation By The Business Research Company

The global oncolytic virus therapy market is segmented –
1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes

The Table Of Content For The Oncolytic Virus Therapy Market Include:
1. Oncolytic Virus Therapy Market Executive Summary
2. Oncolytic Virus Therapy Market Segments
3. Oncolytic Virus Therapy Market Size And Oncolytic Virus Therapy Market Growth Rate
4. Key Oncolytic Virus Therapy Market Trends
5. Major Oncolytic Virus Therapy Market Drivers
……
25. Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market
26. Top Oncolytic Virus Therapy Companies
27. Oncolytic Virus Therapy Market Opportunities And Strategies
28. Oncolytic Virus Therapy Market, Conclusions And Recommendations
29. Appendix

The Oncolytic Virus Therapy Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the oncolytic virus therapy market.

View More Reports Related To The Market –
Solid Tumor Cancer Treatment Global Market Report 2023
Anti Cancer MAbS Global Market Report 2023
Intratumoral Cancer Therapies Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model